Mirum Pharmaceuticals, Inc. Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost
Mirum Pharmaceuticals, Inc. (MIRM) reported Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost of $600.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost · last filed 2021-11-15
- Mirum Pharmaceuticals, Inc. share-based goods and nonemployee services transaction, modification of terms, incremental compensation cost for the quarter ending 2021-03-31 was $300.00K.
| Period end | Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost 3 month | Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost 6 month | Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost 9 month |
|---|---|---|---|
| 2021-09-30 | $600.00K 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $300.00K 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | $300.00K 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |